ReNetx Bio
Dave manages the investment function at Connecticut Innovations. He has extensive senior-level experience in operations and finance, including more than 10 years as Executive Vice President, Treasurer and CFO of CuraGen Corporation, a former CI portfolio company. Dave was also involved in negotiating strategic and business development alliances with several pharmaceutical and biotech companies, including Roche, Bayer and Amgen-Freemont (Abgenix).
This person is not in the org chart
This person is not in any offices
ReNetx Bio
1 followers
Changing lives through the REstoration of neural NETworks. ReNetx Bio's mission is to provide first-in-class therapeutics to treat injury/damage to the central nervous system (CNS) in conditions such as spinal cord injury (SCI), stroke, and glaucoma.